Off-Label Medical and Scientific Information: Reconciling the FDA's Regulatory Mandate with the First Amendment Commercial Free Speech Doctrine

John Osborn spoke on regulatory and legal developments concerning off-label medical information to health policy scholars at the Schaeffer Center for Health Policy and Economics at the University of Southern California in Los Angeles.

Back To Listing
Loading data